MXCT vs SOFI · rev $38.6M vs P/E 39, rev $619.4M
MaxCyte Inc (MXCT) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported SOFI revenue for 2025-12-31 was $619.4M. Net income was $481.3M. Revenue was up 23.1% from 2024-12-31 to 2025-12-31. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
MXCT currently screens at market cap $124.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the MXCT and SOFI stock pages for the full models.
Not investment advice.